Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds Pharmaceuticals US will go public soon. The estimated IPO date is March 3, 2025.

IPO Price Range

$4.00 - $5.00

Shares Offered

4,500,000

Deal Size

$20.25M

APUS Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-1.42	-0.78	-0.67
Share-Based Compensation	-	0.07	0.19
Other Operating Activities	0.36	0.08	0.03
Operating Cash Flow	-1.06	-0.63	-0.45
Share Issuance / Repurchase	-	1.06	-
Debt Issued / Paid	-	-	0.26
Other Financing Activities	1.12	-0.02	0.02
Financing Cash Flow	1.12	1.03	0.28
Net Cash Flow	0.06	0.4	-0.17
Free Cash Flow	-1.06	-0.63	-0.45

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).